Company / R&D Expense
Vivani Medical, Inc. R&D Expense History
FY2015-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$3.0M
FY2017
5-year range
$3.0M / $5.0M
FY2015-FY2017
Trend
-39.8%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3M to $3M over the past 2 years.
Based on SEC 10-K filings.
$3M in FY2017.
Declined from $3M to $3M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, r&d expense decreased 39.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.83 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $3.0M | -39.8% |
| FY2016 | $5.0M | +55.2% |
| FY2015 | $3.2M | - |
As of FY2017 · SEC 10-K · Updated Jun 28, 2026